Icagen News
Most Popular Icagen Story
Angry Icagen backers fire a salvo against Pfizer's $50M buyout
Two big investors behind Icagen are none too happy about Pfizer's deal to snap up a majority of the biotech's shares for $6 each. Longtime venture investor New Leaf Venture Partners joined with Read more...
Latest Headlines
- July 25, 2011
- July 20, 2011
- October 27, 2009
- September 1, 2009
- August 3, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
